209 related articles for article (PubMed ID: 30122918)
1. A GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma.
Zhao M; Liu Z; Dong L; Zhou H; Yang S; Wu W; Lin J
Int J Nanomedicine; 2018; 13():4433-4443. PubMed ID: 30122918
[TBL] [Abstract][Full Text] [Related]
2. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
3. Detecting GPC3-Expressing Hepatocellular Carcinoma with L5 Peptide-Guided Pretargeting Approach: In Vitro and In Vivo MR Imaging Experiments.
Li W; Xiao X; Li X; Xu Y; Ma L; Guo L; Yan C; Wu Y
Contrast Media Mol Imaging; 2018; 2018():9169072. PubMed ID: 30275801
[TBL] [Abstract][Full Text] [Related]
4. Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma.
Li YW; Chen ZG; Zhao ZS; Li HL; Wang JC; Zhang ZM
World J Gastroenterol; 2015 Apr; 21(14):4275-83. PubMed ID: 25892879
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.
Li Y; Chen Z; Li F; Wang J; Zhang Z
Int J Nanomedicine; 2012; 7():4593-611. PubMed ID: 22956868
[TBL] [Abstract][Full Text] [Related]
6. Mouse lymphatic endothelial cell targeted probes: anti-LYVE-1 antibody-based magnetic nanoparticles.
Guo Q; Liu Y; Xu K; Ren K; Sun W
Int J Nanomedicine; 2013; 8():2273-84. PubMed ID: 23818783
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced susceptibility weighted imaging with ultrasmall superparamagnetic iron oxide improves the detection of tumor vascularity in a hepatocellular carcinoma nude mouse model.
Yang SH; Lin J; Lu F; Dai YY; Han ZH; Fu CX; Hu FL; Gu HC
J Magn Reson Imaging; 2016 Aug; 44(2):288-95. PubMed ID: 26808392
[TBL] [Abstract][Full Text] [Related]
8. Bi-specific T1 positive-contrast-enhanced magnetic resonance imaging molecular probe for hepatocellular carcinoma in an orthotopic mouse model.
Ma XH; Chen K; Wang S; Liu SY; Li DF; Mi YT; Wu ZY; Qu CF; Zhao XM
World J Gastrointest Oncol; 2022 Apr; 14(4):858-871. PubMed ID: 35582105
[TBL] [Abstract][Full Text] [Related]
9. Molecular magnetic resonance probe targeting VEGF165: preparation and in vitro and in vivo evaluation.
You XG; Tu R; Peng ML; Bai YJ; Tan M; Li HJ; Guan J; Wen LJ
Contrast Media Mol Imaging; 2014; 9(5):349-54. PubMed ID: 24729581
[TBL] [Abstract][Full Text] [Related]
10. Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.
Bu L; Xie J; Chen K; Huang J; Aguilar ZP; Wang A; Sun KW; Chua MS; So S; Cheng Z; Eden HS; Shen B; Chen X
Contrast Media Mol Imaging; 2012; 7(4):363-72. PubMed ID: 22649042
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall superparamagnetic nanoparticles targeting E-selectin: synthesis and effects in mice in vitro and in vivo.
Liu L; Liu L; Li Y; Huang X; Gu D; Wei B; Su D; Jin G
Int J Nanomedicine; 2019; 14():4517-4528. PubMed ID: 31354271
[No Abstract] [Full Text] [Related]
12. Integrin α
Li D; Dong C; Ma X; Zhao X
Cancer Imaging; 2021 Jun; 21(1):44. PubMed ID: 34187570
[TBL] [Abstract][Full Text] [Related]
13. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
14. Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.
Chen YW; Liou GG; Pan HB; Tseng HH; Hung YT; Chou CP
Int J Nanomedicine; 2015; 10():6997-7018. PubMed ID: 26635474
[TBL] [Abstract][Full Text] [Related]
15. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
[TBL] [Abstract][Full Text] [Related]
16. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
Kou G; Wang S; Cheng C; Gao J; Li B; Wang H; Qian W; Hou S; Zhang D; Dai J; Gu H; Guo Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):192-7. PubMed ID: 18621023
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles.
Cui Y; Zhang C; Luo R; Liu H; Zhang Z; Xu T; Zhang Y; Wang D
Int J Nanomedicine; 2016; 11():5671-5682. PubMed ID: 27895477
[TBL] [Abstract][Full Text] [Related]
18.
Zhao M; Dong L; Liu Z; Yang S; Wu W; Lin J
Quant Imaging Med Surg; 2018 Mar; 8(2):151-160. PubMed ID: 29675356
[TBL] [Abstract][Full Text] [Related]
19. Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.
Frascione D; Diwoky C; Almer G; Opriessnig P; Vonach C; Gradauer K; Leitinger G; Mangge H; Stollberger R; Prassl R
Int J Nanomedicine; 2012; 7():2349-59. PubMed ID: 22661890
[TBL] [Abstract][Full Text] [Related]
20. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
